An update on the CNS actions of TRH and its analogs (Q40859549)

24 September 2017

1 reference

title

An update on the CNS actions of TRH and its analogs (English)

1 reference

24 September 2017

Horita A

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

issue

17-18

1 reference

24 September 2017

page(s)

1443-1448

1 reference

Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Molecular and cellular biology of thyrotropin-releasing hormone receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Influence of NMDA receptor ligands on thyrotropin-releasing hormone-induced scratching in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Thyrotropin-releasing hormone facilitates spinal nociceptive responses by potentiating NMDA receptor-mediated transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Involvement of glutamate and gamma-aminobutyric acid (GABA)-ergic systems in thyrotropin-releasing hormone-induced rat cerebellar cGMP formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

The neuropeptide thyrotropin-releasing hormone modulates GABAergic synaptic transmission on pyramidal neurones of the rat hippocampal slice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effects of TRH on the central nervous system of the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Thyrotropin releasing hormone: antagonism of pentobarbital narcosis in the monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Failure of muscarinic blockade to antagonize analepsis induced by thyrotropin-releasing hormone and MK-771 in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effects of TRH and atropine on induction and duration of anesthesia with propofol in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

TRH and its novel analog (DN-1417): antipentobarbital action and involvement of cholinergic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Montirelin hydrate (NS-3), a TRH analog, improved the disturbance of consciousness caused by head concussion and pentobarbital in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

D1 agonist SKF 38393 antagonizes pentobarbital-induced narcosis and depression of hippocampal and cortical cholinergic activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

[Montirelin hydrate (NS-3), a TRH analog, improved disturbance of consciousness in cats: electroencephalographical studies]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

The TRH analogue MK-771, increases acetylcholine release in hippocampus but not striatum of the conscious rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effect of TA-0910, a novel thyrotropin-releasing hormone analog, on in vivo acetylcholine release and turnover in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effects of a new thyrotropin releasing hormone analogue, YM-14673, on the in vivo release of acetylcholine as measured by intracerebral dialysis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on extracellular acetylcholine and choline levels in the rat frontal cortex and hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (III): Inhibition of pentobarbital anesthesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

TRH attenuates scopolamine-induced memory impairment in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

A peptide enhancement strategy in Alzheimer's disease: pilot study with TRH-physostigmine infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Excitatory action of TRH on spinal motoneurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Mechanisms underlying excitatory effects of thyrotropin-releasing hormone on rat hypoglossal motoneurons in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Thyrotropin-releasing hormone in experimental spinal injury: dose response and late treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Analogs of thyrotropin-releasing hormone in potentiating the spinal monosynaptic reflex in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effect of YM-14673, a new thyrotropin releasing hormone analogue, on ataxic gait in cytosine arabinoside-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900087-3

10.1016/S0024-3205(98)00087-3

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference